Research graph
References from Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)
2020 · External reference
Nanoscale metallic‐organic frameworks as an advanced tool for medical applications: Challenges and recent progress
10.1002/aoc.6982 · 2023 · External reference
Adherence to oral 6-mercaptopurine in African American and Asian children with acute lymphoblastic leukemia: a Children's Oncology Group study
10.1182/blood-2014-01-552166 · 2014 · External reference
Treatment of childhood acute lymphoblastic leukaemia: present issues and future prospects
10.1016/0268-960x(92)90015-i · 1992 · External reference
Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro
10.1097/00054725-200502000-00014 · 2005 · External reference
Adult primary care after childhood acute lymphoblastic leukemia
10.1056/nejmcp1103645 · 2011 · External reference
Recent advances in nanomaterials for colorimetric cancer detection
10.1039/d0tb02163f · 2021 · External reference
Nanocarriers as an emerging platform for cancer therapy
10.1201/9780429399039-2 · 2020 · External reference
Influence of different generations of poly (propylene imine) dendrimers on human erythrocytes
2010 · External reference
Cisplatin-loaded nanoformulations for cancer therapy: A comprehensive review
10.1016/j.jddst.2022.103928 · 2022 · External reference
Novel epirubicin-loaded nanoformulations: advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery
10.1016/j.inoche.2023.110999 · 2023 · External reference
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease
10.1016/j.nano.2018.08.004 · 2018 · External reference
Advances in thiopurine drug delivery: the current state-of-the-art
2021 · External reference
Revolutionizing anticancer drug delivery: Exploring the potential of tamoxifen-loaded nanoformulations
10.1016/j.jddst.2023.104642 · 2023 · External reference
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
10.1039/c8cs00896e · 2019 · External reference
The use of lipid-based nanocarriers for targeted pain therapies
10.3389/fphar.2013.00143 · 2013 · External reference
Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
10.3389/fmolb.2020.00193 · 2020 · External reference
Nanoscaled red blood cells facilitate breast cancer treatment by combining photothermal/photodynamic therapy and chemotherapy
10.1016/j.biomaterials.2017.11.002 · 2018 · External reference
Innovative nanomaterials for cancer diagnosis, imaging, and therapy: drug deliveryapplications
10.1016/j.jddst.2023.104357 · 2023 · External reference
Designing dendrimers for biological applications
10.1038/nbt1171 · 2005 · External reference
Poly (amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation
10.1016/j.nano.2010.10.008 · 2011 · External reference
The development, characterization and in vivo anti-ovarian cancer activity of poly (propylene imine)(PPI)-antibody conjugates containing encapsulated paclitaxel
10.1016/j.nano.2014.09.006 · 2015 · External reference
Polyacrylic acid mediated targeted drug delivery nano-systems: a review
10.1016/j.jddst.2023.104169 · 2023 · External reference
Nanoparticles: properties, applications and toxicities
10.1016/j.arabjc.2017.05.011 · 2019 · External reference
Nanoparticles for colorectal cancer targeted drug delivery and MR imaging: current situation and perspectives
10.2174/1568009616666151130214442 · 2016 · External reference
cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted delivery of fluorouracil
10.1166/jnn.2012.6213 · 2012 · External reference
Quantum-dot-based theranostic micelles conjugated with an anti-EGFR nanobody for triple-negative breast cancer therapy
10.1021/acsami.7b05654 · 2017 · External reference
10.1002/pon.3123
10.1002/pon.3123 · External reference
MERCER, RD-Temporary remission in Acute Leukemia in Children produced by folic antagonist 4-aminopteroyl-glutamic acid (aminopterin)
10.1056/nejm194806032382301 · 1948 · External reference
Adsorption/desorption behaviors and SERS chemical enhancement of 6-mercaptopurine on a nanostructured gold surface: The Au20 cluster model
10.3390/molecules26175422 · 2021 · External reference
Inflammatory bowel disease and corticosteroids: the first RCT
10.1038/s41575-021-00524-3 · 2021 · External reference
Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases
10.1182/blood.v8.11.965.965 · 1953 · External reference
Joe Burchenal and the birth of combination chemotherapy
10.1111/j.1365-2141.2006.06072.x · 2006 · External reference
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia
10.1182/blood.v26.5.642.642 · 1965 · External reference
Acute lymphoblastic leukaemia relapsing as acute myelomonocytic leukaemia after a remission of 7 years
10.1111/j.1365-2141.1980.00495.x · 1980 · External reference
Adherence to oral chemotherapy in acute lymphoblastic leukemia during maintenance therapy in children, adolescents, and young adults: a systematic review
10.3390/curroncol30010056 · 2023 · External reference
Nanoscale drug delivery systems for cancer therapy using paclitaxel—a review of challenges and latest progressions
10.1016/j.jddst.2023.104494 · 2023 · External reference
Folate receptor-targeted and GSH-responsive carboxymethyl chitosan nanoparticles containing covalently entrapped 6-mercaptopurine for enhanced intracellular drug delivery in leukemia
10.3390/md16110439 · 2018 · External reference
Designing chitosan nanoparticles embedded into graphene oxide as a drug delivery system
10.1007/s00289-020-03506-8 · 2022 · External reference
Investigating the structure of the product of graphene oxide reaction with folic acid and chitosan: density functional theory calculations
10.1080/07391102.2021.2001372 · 2022 · External reference
Redox-responsive prodrug-like PEGylated macrophotosensitizer nanoparticles for enhanced near-infrared imaging-guided photodynamic therapy
10.1016/j.ejpb.2018.12.006 · 2019 · External reference
Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies
10.1039/d2na00483f · 2023 · External reference
Research update on cell membrane camouflaged nanoparticles for cancer therapy
2022 · External reference
Preparation of 6-mercaptopurine loaded liposomal formulation for enhanced cytotoxic response in cancer cells
10.3390/nano12224029 · 2022 · External reference
Modified nanofiber containing chitosan and graphene oxide-magnetite nanoparticles as effective materials for smart wound dressing
10.1016/j.compositesb.2021.109557 · 2022 · External reference
New endoscopic finding of esophageal achalasia with ST Hood short type: corona appearance
10.1371/journal.pone.0199955 · 2018 · External reference
Unresolved reference
External reference
Thiopurine drugs in the treatment of ulcerative colitis: identification of a novel deleterious mutation in TPMT
10.3390/genes11101212 · 2020 · External reference
Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer
10.1038/nrc2292 · 2008 · External reference
Thiopurines induce oxidative stress in T-lymphocytes: a proteomic approach
10.1155/2015/434825 · 2015 · External reference
Thiopurine S-methyltransferase polymorphisms predict hepatotoxicity in azathioprine-treated patients with autoimmune diseases
10.3390/jpm12091399 · 2022 · External reference
Implementation of TPMT testing
10.1111/bcp.12226 · 2014 · External reference
The pattern of gene expression and gene dose profiles of 6-Mercaptopurine-and 6-Thioguanine-resistant human leukemia cells
10.1016/j.bbrc.2011.06.120 · 2011 · External reference
ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer
10.3390/cells10102509 · 2021 · External reference
Targeting PI3K/Akt signal transduction for cancer therapy
10.1038/s41392-021-00828-5 · 2021 · External reference
Pharmacogenetics of thiopurines
2019 · External reference
Analytical and sample preparation protocol for therapeutic drug monitoring of 12 thiopurine metabolites related to clinical treatment of inflammatory bowel disease
10.3390/molecules23071744 · 2018 · External reference
Preparation, characterization, pharmacokinetic, and therapeutic potential of novel 6-mercaptopurine-loaded oral nanomedicines for acute lymphoblastic leukemia
10.2147/ijn.s290466 · 2021 · External reference
An overview of polymeric nanoparticles-based drug delivery system in cancer treatment
10.1177/15330338231152083 · 2023 · External reference
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations
10.1038/s41375-022-01591-4 · 2022 · External reference
Unresolved reference
External reference
Nanoparticles and targeted drug delivery in cancer therapy
10.1016/j.imlet.2017.07.015 · 2017 · External reference
6-mercaptopurine (6-MP) entrapped stealth liposomes for improvement of leukemic treatment without hepatotoxicity and nephrotoxicity
10.1080/07357900701224862 · 2007 · External reference
Charge reversal nano-systems for tumor therapy
2022 · External reference
A practical guide to thiopurine prescribing and monitoring in IBD
10.1136/flgastro-2016-100738 · 2018 · External reference
Challenges towards targeted drug delivery in cancer nanomedicines
10.3390/pr9091527 · 2021 · External reference
Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy
10.1016/j.jconrel.2019.06.031 · 2019 · External reference
Prediction of solid fraction from powder mixtures based on single component compression analysis
10.1016/j.ijpharm.2017.03.054 · 2017 · External reference
Progress in polymeric nano-medicines for theranostic cancer treatment
10.3390/polym12030598 · 2020 · External reference
Stimuli-responsive boron-based materials in drug delivery
10.3390/ijms24032757 · 2023 · External reference
Anti-cancerous efficacy and pharmacokinetics of 6-mercaptopurine loaded chitosan nanoparticles
10.1016/j.phrs.2015.07.025 · 2015 · External reference
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
10.2147/ijn.s146315 · 2017 · External reference
Cellular uptake and transport mechanism of 6-mercaptopurine nanomedicines for enhanced oral bioavailability
10.2147/ijn.s394819 · 2023 · External reference
Hyaluronic acid-based nanocarriers for anticancer drug delivery
10.3390/polym15102317 · 2023 · External reference
Recent advances with liposomes as pharmaceutical carriers
10.1038/nrd1632 · 2005 · External reference
Liposome-like nanostructures for drug delivery
10.1039/c3tb21238f · 2013 · External reference
A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives
10.3390/molecules27041372 · 2022 · External reference
Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: a review
10.1016/j.jksus.2017.10.004 · 2019 · External reference
Characterization and functionalization approaches for the study of polymeric nanoparticles: The state of the art in Italian research
10.3390/micro3010002 · 2023 · External reference
Biodegradable polymeric nanoparticles loaded with flavonoids: a promising therapy for inflammatory bowel disease
10.3390/ijms24054454 · 2023 · External reference
Biodegradable polymeric nanoparticles for drug delivery to solid tumors
10.3389/fphar.2021.601626 · 2021 · External reference
Dendrimers as nanocarriers for the delivery of drugs obtained from natural products
10.3390/polym15102292 · 2023 · External reference
Recent progress and advances of multi-stimuli-responsive dendrimers in drug delivery for cancer treatment
10.3390/pharmaceutics11110591 · 2019 · External reference
Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release
10.1016/j.ejpb.2004.09.005 · 2005 · External reference
Applications and limitations of dendrimers in biomedicine
10.3390/molecules25173982 · 2020 · External reference
Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
10.4103/0975-7406.130965 · 2014 · External reference
Solid lipid nanoparticles: a modern formulation approach in drug delivery system
10.4103/0250-474x.57282 · 2009 · External reference
Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration
2022 · External reference
Bioactive loaded novel nano-formulations for targeted drug delivery and their therapeutic potential
10.3390/pharmaceutics14051091 · 2022 · External reference
3D printing by fused deposition modeling of single-and multi-compartment hollow systems for oral delivery–a review
10.1016/j.ijpharm.2020.119155 · 2020 · External reference
Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro
10.1166/jbn.2012.1358 · 2012 · External reference
A Concise review on application of solid lipids and various techniques in the formulation development
10.22270/jddt.v13i5.5817 · 2023 · External reference
Combinational system of lipid-based nanocarriers and biodegradable polymers for wound healing: an updated review
10.3390/jfb14020115 · 2023 · External reference
Applications of nanosized-lipid-based drug delivery systems in wound care
10.3390/app11114915 · 2021 · External reference
Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
10.1186/s43094-022-00414-8 · 2022 · External reference
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
10.1016/j.ejps.2012.05.010 · 2012 · External reference
Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride
10.1016/j.ejps.2013.03.013 · 2013 · External reference
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
10.1016/j.ejpb.2011.02.012 · 2011 · External reference
Recent fabrication methods to produce polymer-based drug delivery matrices (experimental and in silico approaches)
10.3390/pharmaceutics14040872 · 2022 · External reference
Anticancer drugs: recent strategies to improve stability profile, pharmacokinetic and pharmacodynamic properties
10.3390/molecules27175436 · 2022 · External reference
Polymeric micelles for multi-drug delivery in cancer
10.1208/s12249-014-0251-3 · 2015 · External reference
A ROS-responsive fluorescent probe detecting experimental colitis by functional polymeric nanoparticles
10.1016/j.ijpharm.2021.121125 · 2021 · External reference
Gold nanostructure-mediated delivery of anti-cancer agents: biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers.
10.1016/j.envres.2023.115673 · 2023 · External reference
Tumor microenvironment-responsive 6-mercaptopurine-releasing injectable hydrogel for colon cancer treatment
10.3390/gels9040319 · 2023 · External reference
Small interfering RNA from the lab discovery to patients' recovery
10.1016/j.jconrel.2020.02.032 · 2020 · External reference
Current status, challenges and future outlook of high performance polymer semiconductors for organic photovoltaics modules
10.1016/j.progpolymsci.2019.02.002 · 2019 · External reference
Association between proton pump inhibitors and asthma: a population-based cohort study
10.3389/fphar.2020.00607 · 2020 · External reference
Functionalization of polysulfide nanoparticles and their performance as circulating carriers
10.1016/j.biomaterials.2007.12.035 · 2008 · External reference
Speech delivered in the graduation ceremony of the residents of the class of 2014 of the Instituto Nacional de Cardiología Ignacio Chávez
10.1016/j.acmx.2016.01.001 · 2016 · External reference
Polyvinyl alcohol based-drug delivery systems for cancer treatment
10.1016/j.ijpharm.2021.120478 · 2021 · External reference
An up-to-date review of natural nanoparticles for cancer management
10.3390/pharmaceutics14010018 · 2021 · External reference
Inhalable liposomal dry powder of gemcitabine-HCl: Formulation, in vitro characterization and in vivo studies
10.1016/j.ijpharm.2015.10.020 · 2015 · External reference
Progress in polymeric micelles for drug delivery applications
10.3390/pharmaceutics14081636 · 2022 · External reference
Polymeric nanoparticles for targeted treatment in oncology: current insights
2015 · External reference
BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis
10.1016/j.lungcan.2015.07.017 · 2015 · External reference
Identification of genomic alterations in oesophageal squamous cell cancer
10.1038/nature13176 · 2014 · External reference
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
10.1038/nprot.2008.211 · 2009 · External reference
A randomized longitudinal dietary intervention study during pregnancy: effects on fish intake, phospholipids, and body composition
10.1186/1475-2891-14-1 · 2015 · External reference
Zinc forms of faujasite zeolites as a drug delivery system for 6-mercaptopurine
10.1016/j.micromeso.2022.112194 · 2022 · External reference
Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis
10.1093/ibd/izy123 · 2018 · External reference
Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies
10.1021/acs.chemrev.5b00589 · 2016 · External reference
Mesoporous silica modified with polydopamine and zinc ions as a potential carrier in the controlled release of mercaptopurine
10.3390/ma16124358 · 2023 · External reference
Meeting challenges of pediatric drug delivery: the potential of orally fast disintegrating tablets for infants and children
10.3390/pharmaceutics15041033 · 2023 · External reference
H. 409 Yeger. Combination therapy in combating cancer
10.18632/oncotarget.16723 · 2017 · External reference
Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells–Effects on gene expression levels and thiopurine metabolism
10.1371/journal.pone.0173825 · 2017 · External reference
Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance
10.1016/j.cgh.2015.09.037 · 2016 · External reference
Purines 2010: adenine nucleosides and nucleotides in biomedicine
2010 · External reference
Clinical pharmacokinetics of the phosphate binder lanthanum carbonate
10.2165/00003088-200847090-00001 · 2008 · External reference
EspA is a novel fusion partner for expression of foreign proteins in Escherichia coli
10.1016/j.jbiotec.2010.09.940 · 2010 · External reference
Development of bio-based fine chemical production through synthetic bioengineering
10.1186/s12934-014-0173-5 · 2014 · External reference
Therapeutic drug monitoring of antimetabolic cytotoxic drugs
10.1046/j.1365-2125.1999.00884.x · 1999 · External reference
Development and validation of LC–MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism
10.1016/j.jchromb.2016.10.035 · 2016 · External reference
Unresolved reference
External reference
Therapeutic drug monitoring for current and investigational inflammatory bowel disease treatments
10.1097/mcg.0000000000001396 · 2021 · External reference
Improved HPLC quantification of 6-mercaptopurine metabolites in red blood cells: monitoring data and literature analysis
10.3390/ijms231911885 · 2022 · External reference
LC–MS/MS method for measurement of thiopurine nucleotides (TN) in erythrocytes and association of TN concentrations with TPMT enzyme activity
10.3389/fphar.2022.836812 · 2022 · External reference
Quantification of 6-mercaptopurine and its metabolites in patients with acute lympoblastic leukemia using dried blood spots and UPLC-MS/MS
2018 · External reference
Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease
10.3748/wjg.v17.i37.4166 · 2011 · External reference
Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 h
10.7326/0003-4819-126-8-199704150-00005 · 1997 · External reference
Population pharmacokinetics of voriconazole in patients with invasive aspergillosis: serum albumin level as a novel marker for clearance and dosage optimization
10.1097/ftd.0000000000000799 · 2020 · External reference
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
10.1111/j.1742-4658.2011.08235.x · 2011 · External reference
Inhibit or evade multidrug resistance P-glycoprotein in cancer treatment: Miniperspective
10.1021/acs.jmedchem.7b01457 · 2017 · External reference
Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?
10.1124/dmd.113.056176 · 2014 · External reference
Understanding and targeting resistance mechanisms in cancer
10.1002/mco2.265 · 2023 · External reference
A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy
2020 · External reference
Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential
10.1007/s13346-016-0304-0 · 2016 · External reference
Use of thiopurines in inflammatory bowel disease: an update
10.5217/ir.2020.00155 · 2022 · External reference
Unresolved reference
External reference
Patient counseling about herbal-drug interactions
10.4314/ajtcam.v8i5s.8 · 2011 · External reference
Effect of the BH3 mimetic polyphenol (–)-gossypol (AT-101) on the in vitro and in vivo growth of malignant mesothelioma
10.3389/fphar.2018.01269 · 2018 · External reference
Recent advances in nanoparticle-based co-delivery systems for cancer therapy
10.3390/nano12152672 · 2022 · External reference
Use of allopurinol to mitigate 6-mercaptopurine associated gastrointestinal toxicity in acute lymphoblastic leukemia
10.3389/fonc.2020.01129 · 2020 · External reference
Smart co-delivery of 6-mercaptopurine and methotrexate using disulphide-based PEGylated-nanogels for effective treatment of breast cancer
10.1039/c9nj02470k · 2019 · External reference
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
10.1182/blood-2003-12-4428 · 2004 · External reference
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease
10.1097/00042737-200012110-00010 · 2000 · External reference
Drug delivery to resistant tumors: the potential of poly (alkyl cyanoacrylate) nanoparticles
10.1016/j.jconrel.2003.08.005 · 2003 · External reference
Engineered nanoparticles against MDR in cancer: the state of the art and its prospective
10.2174/1381612822666160617112111 · 2016 · External reference
Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
10.1080/10717544.2017.1410256 · 2017 · External reference
APEX1 polymorphism and mercaptopurine-related early onset neutropenia in pediatric acute lymphoblastic leukemia
2018 · External reference
Targeting tumor microenvironment for cancer therapy
10.3390/ijms20040840 · 2019 · External reference
Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
10.1007/s00280-020-04097-x · 2020 · External reference
Advances in lipid‐based codelivery systems for cancer and inflammatory diseases
10.1002/adhm.202202400 · 2023 · External reference
Prodrugs for improved drug delivery: lessons learned from recently developed and marketed products
10.3390/pharmaceutics12111031 · 2020 · External reference
Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
10.1111/j.1365-2125.2010.03867.x · 2011 · External reference
Nanocarrier-based systems for targeted and site specific therapeutic delivery
10.1016/j.addr.2019.07.010 · 2019 · External reference
Nanoparticles as drug delivery systems: a review of the implication of nanoparticles’ physicochemical properties on responses in biological systems
10.3390/polym15071596 · 2023 · External reference
Receptor-targeted nanocarriers for therapeutic delivery to cancer
10.3109/09687688.2010.521200 · 2010 · External reference
Advances in chitosan-based nanoparticles for drug delivery
10.3390/ijms22179652 · 2021 · External reference
Nanocarriers for methotrexate delivery/codelivery in the frame of cancer diagnostics and treatment: a review
10.3389/fbiom.2023.1200670 · 2023 · External reference
Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
10.2217/nnm-2018-0120 · 2019 · External reference
Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine
10.1016/j.gpb.2016.03.008 · 2016 · External reference
Combination therapeutics in complex diseases
10.1111/jcmm.12930 · 2016 · External reference
